Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rachel Michowiz"'
Autor:
Eyal Robenshtok, Alon Grossman, Rachel Michowiz, Ilan Shimon, Ronit Koren, Ruth Rahamimov, Zippora Shohat, Eytan Mor, Amit Tirosh
Publikováno v:
Endocrine Research. 41:98-102
The prevalence of adrenal incidentalomas (AIs) in asymptomatic individuals is unknown. This study evaluated the prevalence of AIs in healthy kidney donors in whom pre-operative computed tomography (CT) is performed routinely.All potential kidney dono
Autor:
Sigal, Eisner, Jacob, Orlin, Eviatar, Nesher, Vadym, Mazhybovsky, Michael, Gurevich, Rachel, Michowiz, Ruth, Rahamimov, Eytan, Mor
Publikováno v:
Harefuah. 156(4)
With the introduction of new therapies, the ABO barrier for kidney transplantation has been breached. In the recent decade the reported results with ABO incompatible (ABOi) kidney transplantation are similar to ABO compatible transplantation. We repo
Autor:
Amir Shlomai, Orly Sneh Arbib, Sigal Cohen, Eytan Mor, Michal Cohen-Naftaly, Assaf Issachar, Ran Tur-Kaspa, Marius Braun, Rachel Michowiz
Publikováno v:
Journal of Hepatology. 70:e561
Publikováno v:
Human Immunology. 66:21-27
Recurrence of hepatitis C in liver transplant recipients is a common event that often leads to loss of the allograft. There are no means to prevent, or even predict, those patients who are more prone to early aggressive recurrence. Therefore there is
Autor:
R Tur-Kaspa, Rachel Michowiz, Eytan Mor, John W. Ortegel, Anat R. Tambur, Ziv Ben-Ari, Tirza Klein, Eti Shabtai
Publikováno v:
Transplantation. 71:1475-1480
Background. Cytokines play a key role in the regulation of immune responses. The maximal capacity of cytokine production varies between individuals and was shown to correlate with polymorphism in cytokine gene promoters. The objective of this study w
Autor:
Marius Brown, N Bar-Nathan, Z Shapira, R Tur-Kaspa, Ziv Ben-Ari, Rachel Michowiz, A Yussim, E Mor, E Shaharabani
Publikováno v:
Transplantation Proceedings. 35:617-618
WITH THE SEVERE organ shortage worldwide there has been a trend in recent years toward an increased use of liver allografts from older and otherwise suboptimal donors. The main disadvantage of this donor pool is the increased risk for primary graft n